A sweeping study of more than 400,000 women has revealed that polyendocrine metabolic ovarian syndrome carries a cardiovascular burden far greater than medicine has accounted for — and far stranger. Young women with PMOS face more than triple the risk of heart attack and stroke compared to their peers, yet only a third of that danger can be traced to the familiar villains of obesity, diabetes, or high blood pressure. The remaining two-thirds point toward something deeper in the biology of the condition itself, quietly reshaping what it means to care for women in their reproductive years.
PMOS linked to 340% higher CVD risk in young women beyond obesity, diabetes
Young women with PMOS face significantly elevated cardiovascular disease risk, potentially affecting reproductive-age population health outcomes.